{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Faricimab+Injection&page=2", "query": { "intervention": "Faricimab Injection", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Faricimab+Injection&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-24T02:09:16.029Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04432831", "title": "A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Faricimab", "type": "DRUG" }, { "name": "Sham Procedure", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1479, "start_date": "2020-08-05", "completion_date": "2023-10-11", "has_results": true, "last_update_posted_date": "2026-02-09", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 119, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 105 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04432831" }, { "nct_id": "NCT03622580", "title": "A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Aflibercept", "type": "DRUG" }, { "name": "Faricimab", "type": "DRUG" }, { "name": "Sham Procedure", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 940, "start_date": "2018-09-05", "completion_date": "2021-09-03", "has_results": true, "last_update_posted_date": "2025-07-11", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 85, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 78 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Campbell", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03622580" }, { "nct_id": "NCT06850922", "title": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "RO7446603", "type": "DRUG" }, { "name": "Aflibercept", "type": "DRUG" }, { "name": "Faricimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 388, "start_date": "2022-06-22", "completion_date": "2026-06-19", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 70, "location_summary": "Phoenix, Arizona • Springdale, Arkansas • Campbell, California + 60 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Campbell", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06850922" }, { "nct_id": "NCT04740905", "title": "A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Macular Edema", "Branch Retinal Vein Occlusion" ], "interventions": [ { "name": "Faricimab", "type": "DRUG" }, { "name": "Aflibercept", "type": "DRUG" }, { "name": "Sham Procedure", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 553, "start_date": "2021-03-02", "completion_date": "2023-06-12", "has_results": true, "last_update_posted_date": "2024-08-06", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 39, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Campbell, California + 36 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Campbell", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04740905" }, { "nct_id": "NCT05610319", "title": "Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Faricimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "McMaster University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 446, "start_date": "2023-05-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-04-17", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 11, "location_summary": "Modesto, California • Sacramento, California • Oak Forest, Illinois + 7 more", "locations": [ { "city": "Modesto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Oak Forest", "state": "Illinois" }, { "city": "West Monroe", "state": "Louisiana" }, { "city": "Jackson", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT05610319" }, { "nct_id": "NCT06795048", "title": "A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Neovascular Age-related Macular Degeneration (nAMD)" ], "interventions": [ { "name": "Faricimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 274, "start_date": "2025-03-14", "completion_date": "2027-09-20", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 11, "location_summary": "Santa Ana, California • Orlando, Florida • Winter Haven, Florida + 8 more", "locations": [ { "city": "Santa Ana", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Winter Haven", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Lemont", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06795048" }, { "nct_id": "NCT07695298", "title": "A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Presumed Ocular Histoplasmosis" ], "interventions": [ { "name": "Faricimab Injection [Vabysmo]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cincinnati Eye Institute, Southwest Ohio", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2026-07", "completion_date": "2028-05", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 2, "location_summary": "Cincinnati, Ohio • Dayton, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" }, { "city": "Dayton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07695298" }, { "nct_id": "NCT04597918", "title": "A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Diabetic Macular Edema Treated With Faricimab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Faricimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 99, "start_date": "2020-11-25", "completion_date": "2022-12-22", "has_results": true, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 12, "location_summary": "Naples, Florida • Chicago, Illinois • Oak Forest, Illinois + 9 more", "locations": [ { "city": "Naples", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Oak Forest", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Hagerstown", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04597918" }, { "nct_id": "NCT05569148", "title": "A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neovascular Age-related Macular Degeneration", "Diabetic Macular Edema" ], "interventions": [ { "name": "Faricimab PFS Configuration", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2022-10-17", "completion_date": "2022-11-10", "has_results": true, "last_update_posted_date": "2023-10-10", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 3, "location_summary": "Mesa, Arizona • Phoenix, Arizona", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05569148" }, { "nct_id": "NCT03823300", "title": "A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Wet Macular Degeneration" ], "interventions": [ { "name": "Faricimab", "type": "DRUG" }, { "name": "Aflibercept", "type": "DRUG" }, { "name": "Sham Procedure", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 658, "start_date": "2019-03-11", "completion_date": "2022-01-07", "has_results": true, "last_update_posted_date": "2025-07-11", "last_synced_at": "2026-09-24T02:09:16.029Z", "location_count": 41, "location_summary": "Phoenix, Arizona • Mountain View, California • Sacramento, California + 36 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Mountain View", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03823300" } ] }